MicroTransponder is developing a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications.  The minimally invasive device will provide relief from chronic pain without requiring an implanted battery or wires. Patients experiencing refractory chronic pain will have an effective device based treatment.  The Company is finishing R&D on the device and accumulating data toward FDA clearance.  MicroTransponder  is developing a device platform for a pipeline of additional indications based on Vagus Nerve Stimulation, including stroke rehabilitation, tinnitus, and anxiety.

 *Investigational device only, not for sale

Latest News